Evidence map›Paper›PMID 34633213›Full record

ArticleThe Journal of urology2022

Reply by Authors.

Cheyenne Williams, Michael Ahdoot, Michael A Daneshvar, Christian Hague, Andrew R Wilbur, Patrick T Gomella, Joanna Shih, Nabila Khondakar, Nitin Yerram, Sherif Mehralivand and 8 more

Abstract readComment
PubMed Publisher
In one paragraph

Article in The Journal of urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Cheyenne WilliamsUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Michael AhdootUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Michael A DaneshvarUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Christian HagueUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Andrew R WilburUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Patrick T GomellaUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Joanna ShihBiometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Nabila KhondakarUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Nitin YerramUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Sherif MehralivandMolecular Imaging Program, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland.
Sandeep GurramUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Minhaj SiddiquiDirector of Urologic Oncology and Robotic Surgery, VA Medical Center, University of Maryland, Baltimore, Maryland.
Paul PinskyDivision of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Howard ParnesDivision of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Maria MerinoTranslational Surgical Pathology Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Bradford WoodCenter for Interventional Oncology, National Cancer Institute, & Interventional Radiology, Radiology and Imaging Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Baris TurkbeyMolecular Imaging Program, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland.
Peter A PintoUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Funding

Center for Interventional OncologyZIDBC011242 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WOOD, BRADFORD J · 2009 to 2025
$18.7M
Prostate SectionZIABC011081 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI PINTO, PETER · 2009 to 2025
$15.2M
Imaging, image guided biopsy and treatment of prostate cancerZIABC012062 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TÜRKBEY, BARIS · 2021 to 2025
$1.3M
Navigation Tools for Image Guided Minimally invasive TherapiesZIACL040011 · CLC · CLINICAL CENTER · PI WOOD, BRADFORD · 2009 to 2025
$0k
Interventional OncologyZIACL040015 · CLC · CLINICAL CENTER · PI WOOD, BRADFORD · 2009 to 2025
$0k
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34633213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.